Leap Therapeutics Stock Overlap Studies Hilbert Transform Instantaneous Trendline

LPTX Stock  USD 2.95  0.03  1.03%   
Leap Therapeutics overlap studies tool provides the execution environment for running the Hilbert Transform Instantaneous Trendline study and other technical functions against Leap Therapeutics. Leap Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Hilbert Transform Instantaneous Trendline study function is designed to identify and follow existing trends. Leap Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques.

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Leap Therapeutics price series.

Leap Therapeutics Technical Analysis Modules

Most technical analysis of Leap Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Leap from various momentum indicators to cycle indicators. When you analyze Leap charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Leap Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Leap Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Leap Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Leap Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Leap Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Leap Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Leap Therapeutics, we also check how macroeconomic factors affect Leap Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2010 2023 2024 (projected)
Dividend Yield0.01420.002610.00248
Price To Sales Ratio88.99166.84109.75
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Leap Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.152.968.39
Details
Intrinsic
Valuation
LowRealHigh
1.246.6712.10
Details
4 Analysts
Consensus
LowTargetHigh
16.4718.1020.09
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.47-0.46-0.45
Details

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

Leap Therapeutics pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Leap Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leap Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Leap Therapeutics Pair Trading

Leap Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Leap Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Leap Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Leap Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Leap Therapeutics to buy it.
The correlation of Leap Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Leap Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Leap Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Leap Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Leap Stock Analysis

When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.